Roche in $4.3bn deal to buy gene therapy company Spark Therapeutics

Roche acquisition of Spark Therapeutics : Swiss pharma giant Roche has signed an all-cash deal worth $4.3 billion to acquire US gene therapy company Spark Therapeutics, as per the latest pharma acquisition news. Roche acquisition of Spark Therapeutics According to the merger terms, Roche will offer to buy 100% of Spark Therapeutics for $ 114.50 per More...

by pharmanewsdaily | Published 3 weeks ago
By pharmanewsdaily On Sunday, March 31st, 2019
0 Comments

Xeris Pharmaceuticals begins dosing in phase 2 trial of ready-to-use glucagon

US pharma company Xeris Pharmaceuticals announced that it has started dosing in a phase 2 trial with its ready-to-use, room temperature stable liquid glucagon in Type 1 diabetes patients who face episodes of exercise-induced More...

By pharmanewsdaily On Saturday, March 30th, 2019
0 Comments

Tecentriq wins FDA approval for extensive stage small cell lung cancer

Tecentriq FDA approval : Roche subsidiary Genetech has bagged a new approval from the US Food and Drug Administration (FDA) for Tecentriq (atezolizumab), this time in combination with chemotherapy as the first-line More...

By pharmanewsdaily On Sunday, March 24th, 2019
0 Comments

Praluent bags EC approval to reduce risk of CV events in patients with ASCD

Regeneron Pharmaceuticals and Sanofi have secured approval for Praluent (alirocumab) for a new indication from the European Commission (EC), which is for the reduction of cardiovascular risk in adults with established More...

By pharmanewsdaily On Saturday, March 23rd, 2019
0 Comments

Boston Scientific’s LUMINIZE RF Balloon Catheter meets objective in AF-FICIENT I trial

Boston Scientific said that its LUMINIZE Radiofrequency (RF) Balloon Catheter (LUMINIZE RF Balloon Catheter), which is intended to be used for isolating pulmonary veins during treatment of patients with atrial fibrillation More...

By pharmanewsdaily On Thursday, March 21st, 2019
0 Comments

Stryker acquires Israeli medical device company OrthoSpace

Stryker acquisition of OrthoSpace : US medical technologies firm Stryker has acquired an Israeli medical device company OrthoSpace in an all-cash deal worth up to $220 million. As per the deal terms, Stryker made More...

By pharmanewsdaily On Saturday, March 16th, 2019
0 Comments

Biotronik’s Acticor and Rivacor CRM devices bag FDA approval

Biotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices – Acticor and Rivacor range of devices for treating heart arrhythmia or cardiac arrhythmias. The six new tachycardia More...

By pharmanewsdaily On Saturday, March 16th, 2019
0 Comments

Blackstone to acquire Japanese specialty pharma company AYUMI

Blackstone acquisition of AYUMI : Global investment firm Blackstone said that private equity funds managed by it will acquire Japanese specialty pharma company AYUMI Pharmaceutical from Unison Capital and M3 for More...

By pharmanewsdaily On Wednesday, March 13th, 2019
0 Comments

X4 Pharmaceuticals wraps up merger with Arsanis

X4 Pharmaceuticals has completed its previously announced merger with Arsanis in a move to create a late-stage biopharma company focused on rare diseases and cancer. Both companies are based in Massachusetts. X4 More...

By pharmanewsdaily On Saturday, March 9th, 2019
0 Comments

Lilly wraps up $8bn acquisition of Loxo Oncology

US pharma giant Eli Lilly and Company (Lilly) has wrapped up its previously announced $8 billion acquisition of Connecticut-based biopharma company Loxo Oncology. Announced in January 2019, Lilly acquisition of More...